Governing nonconventional genetic experimentation.

Authors:
Mehlman MJ; Conlon RA; Pearlman A.

Journal:
J Law Biosci

Publication Year: 2023

DOI:
10.1093/jlb/lsad003

PMCID:
PMC9997442

PMID:
36910719

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Law Biosci

Abbreviation: J Law Biosci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Legal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anticipation in the biosciences and the human right to science.
Boggio A. (2024) - Transparency Score: 2/6
CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and …
Pacia DM; Brown BL; Minssen T and 1 more (2024) - Transparency Score: 3/6
Purpose definition as a crucial step for determining the legal basis under the GDPR: implications f…
Becker R; Chokoshvili D; Thorogood A and 5 more (2024) - Transparency Score: 2/6
Cryopreservation and current legal problems: seeking and selling immortality.
Mullock A; Romanis EC. (2023) - Transparency Score: 2/6
Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and s…
Dalpé G; Huerne K; Dupras C and 14 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Francis S. Collins, Statement on NIH Funding of Research Using Gene-Editing Technologies in Human Embryos , Nat ’ l   Institute of   Health (Apr. 28, 2015), http://www.nih.gov/about-nih/who-we-are/nih-director/statements/statement-nih-funding-research-using-gene-editing-technologies-human-embryos ."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025